Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Non-Current Deffered Revenue (2016 - 2017)

Historic Non-Current Deffered Revenue for Nephros (NEPH) over the last 7 years, with Q4 2017 value amounting to $208000.0.

  • Nephros' Non-Current Deffered Revenue fell 2517.99% to $208000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $208000.0, marking a year-over-year decrease of 2517.99%. This contributed to the annual value of $208000.0 for FY2017, which is 2517.99% down from last year.
  • Latest data reveals that Nephros reported Non-Current Deffered Revenue of $208000.0 as of Q4 2017, which was down 2517.99% from $225000.0 recorded in Q3 2017.
  • In the past 5 years, Nephros' Non-Current Deffered Revenue ranged from a high of $531000.0 in Q1 2013 and a low of $176000.0 during Q3 2013
  • Its 5-year average for Non-Current Deffered Revenue is $333833.3, with a median of $338500.0 in 2015.
  • In the last 5 years, Nephros' Non-Current Deffered Revenue plummeted by 8002.27% in 2013 and then surged by 14659.09% in 2014.
  • Over the past 5 years, Nephros' Non-Current Deffered Revenue (Quarter) stood at $176000.0 in 2013, then skyrocketed by 136.93% to $417000.0 in 2014, then dropped by 16.79% to $347000.0 in 2015, then dropped by 19.88% to $278000.0 in 2016, then fell by 25.18% to $208000.0 in 2017.
  • Its last three reported values are $208000.0 in Q4 2017, $225000.0 for Q3 2017, and $243000.0 during Q2 2017.